BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1303143)

  • 1. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.
    Dersch CM; Akunne HC; Partilla JS; Char GU; de Costa BR; Rice KC; Carroll FI; Rothman RB
    Neurochem Res; 1994 Feb; 19(2):201-8. PubMed ID: 8183430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine.
    Rothman RB; Mele A; Reid AA; Akunne HC; Greig N; Thurkauf A; de Costa BR; Rice KC; Pert A
    Pharmacol Biochem Behav; 1991 Oct; 40(2):387-97. PubMed ID: 1839568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
    Valchar M; Hanbauer I
    J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
    Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
    Rothman RB; Mele A; Reid AA; Akunne H; Greig N; Thurkauf A; Rice KC; Pert A
    FEBS Lett; 1989 Nov; 257(2):341-4. PubMed ID: 2583282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS; Baldessarini RJ
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters.
    Rothman RB; Lewis B; Dersch C; Xu H; Radesca L; de Costa BR; Rice KC; Kilburn RB; Akunne HC; Pert A
    Synapse; 1993 May; 14(1):34-9. PubMed ID: 8511716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction.
    Simantov R
    Neurosci Lett; 1993 Dec; 163(2):121-4. PubMed ID: 8309616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [(3)H]GBR12935 binding and [(3)H]dopamine uptake.
    Sharif NA; Nunes JL; Michel AD; Whiting RL
    Neurochem Int; 1989; 15(3):325-32. PubMed ID: 20504502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging.
    Shimizu I; Prasad C
    J Neurochem; 1991 Feb; 56(2):575-9. PubMed ID: 1988557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
    Bonnet JJ; Protais P; Chagraoui A; Costentin J
    Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cocaine analog and a GBR analog label the same protein in rat striatal membranes.
    Patel A; Boja JW; Lever J; Lew R; Simantov R; Carroll FI; Lewin AH; Philip A; Gao Y; Kuhar MJ
    Brain Res; 1992 Mar; 576(1):173-4. PubMed ID: 1515909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.
    Schoemaker H; Pimoule C; Arbilla S; Scatton B; Javoy-Agid F; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):227-35. PubMed ID: 3927176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.